<?xml version="1.0" encoding="UTF-8"?>
<p id="Par89">Also on April 26, 2020, Scientists from Stony Brook University’s Renaissance School of Medicine, Northwell Health’s Feinstein Institutes for Medical Research and Catholic Health Services started searching to clarify if the antibodies in plasma from recovering COVID-19-infected cases can help stop the infection in people who are still sick or not. Dr. Jason M. Golbin, Catholic Health’s senior vice president and chief quality officer, confessed he is “cautiously optimistic” about this remedy but concedes it will be months before they can define if it’s effective and safe. Up to now, Catholic Health has transmitted 140 convalescent plasma transfusions at its six Long Island hospitals (
 <ext-link ext-link-type="uri" xlink:href="https://news.sky.com/story/coronavirus-plasma-treatment-for-covid-19-patients-to-be-trialled-11978522" xmlns:xlink="http://www.w3.org/1999/xlink">https://news.sky.com/story/coronavirus-plasma-treatment-for-covid-19-patients-to-be-trialled-11978522</ext-link>).
</p>
